We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.00
Bid: 63.20
Ask: 66.00
Change: -1.00 (-1.54%)
Spread: 2.80 (4.43%)
Open: 64.60
High: 66.00
Low: 64.00
Prev. Close: 65.00
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Idox PLC)

5 Mar 2021 11:12

RNS Number : 3438R
IDOX PLC
05 March 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Idox plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Idox plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

4 March 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 0.1p in Idox plc

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0.000

Nil

0.000

(2) Cash-settled derivatives:

 

Nil

0.000

Nil

0.000

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0.000

Nil

0.000

 

TOTAL:

Nil

0.000

Nil

0.000

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(A) Interests held by the directors of Idox plc and their close relatives and related trusts:

 

Director

No. of ordinary shares of 0.1p each held

Percentage of issued share capital

Chris Stone

936,377

0.21%

David Meaden

468,139

0.11%

Robert Grubb

88,885

0.02%

Phil Kelly

105,263

0.02%

 

(B) Interests held as options or awards by directors of Idox plc under the Idox Long Term Incentive Plan 2019 ("LTIP") and under a matching share agreement entered into between the relevant director and Idox ("MSA") which have vested but where the director has not exercised their right to acquire or receive the shares:

 

Director

Scheme

Award date

No. of ordinary shares of 0.1p each under option / award (2)

Vesting date

Percentage of issued share capital

Robert Grubb

LTIP

18 March 2019

333,333

18 March 2020

0.07%

David Meaden

LTIP

12 March 2019

1,170,800

12 March 2020

0.3%

Chris Stone

MSA

11 March 2019

585,500

11 March 2019

0.13%

 

(C) Interests held as options or awards by directors of Idox plc under the Idox Long Term Incentive Plan 2019 ("LTIP") which have not yet vested:

 

Director

Scheme

Award date

No. of ordinary shares of 0.1p each under option / award (2)

Vesting date

Percentage of issued share capital

Robert Grubb

LTIP

18 March 2019

333,333

18 March 2021

0.07%

18 March 2019

333,334

18 March 2022

0.07%

LTIP

18 March 2020

108,024

18 March 2021

0.02%

18 March 2020

108,025

18 March 2022

0.02%

18 March 2020

108,025

18 March 2023

0.02%

David Meaden

LTIP

12 March 2019

1,170,800

12 March 2021

0.3%

12 March 2019

1,170,800

12 March 2022

0.3%

 

(2) The number shown in this column is the maximum number of ordinary shares which are capable of being acquired in connection with that option or award. The actual number of shares which may be acquired may be more or less, depending on performance against any applicable performance conditions.

 

(D) Interests of Idox Trustees Limited, in its capacity as trustee of the Idox plc Employee Benefit Trust

 

Class of relevant security

Ordinary shares of 0.1p each in Idox plc

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

3,522,022

0.79%

0

0.000%

(2) Cash-settled derivatives

0

0.000%

0

0.000%

(3) Stock-settled derivatives

0

0.000%

0

0.000%

 

 

 

Class of relevant security

Ordinary shares of 0.1p each in Idox plc

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

%

0

0.000%

(2) Cash-settled derivatives

0

0.000%

0

0.000%

(3) Stock-settled derivatives

0

0.000%

0

0.000%

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 March 2021

Contact name:

Ruth Paterson

Telephone number:

03330111636

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUVAARARUORAR
Date   Source Headline
24th Apr 20247:00 amRNSReplacement: Total Voting Rights
17th Apr 202412:43 pmRNSTotal Voting Rights
28th Mar 20245:22 pmRNSHolding(s) in Company
28th Mar 202412:37 pmRNSDirector/PDMR Shareholding
28th Mar 202411:21 amRNSResult of AGM
28th Mar 20247:00 amRNSAGM Trading update
22nd Mar 20245:42 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 20248:40 amRNSHolding(s) in Company
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Mar 20245:12 pmRNSPosting of Annual Report and Notice of AGM
14th Feb 20241:39 pmRNSHolding(s) in Company
9th Feb 20247:00 amRNSExercise of Share Options & Total Voting Rights
25th Jan 20247:00 amRNSFinal Results
18th Jan 202412:35 pmRNSNotice of Final Results
17th Jan 20247:00 amRNSExercise of Share Options & Total Voting Rights
27th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 20237:00 amRNSYear End Trading Update
9th Nov 202310:25 amRNSHolding(s) in Company
6th Nov 20233:01 pmRNSHolding(s) in Company
2nd Nov 20232:10 pmRNSHolding(s) in Company
2nd Nov 202310:09 amRNSHolding(s) in Company
1st Nov 202311:48 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAdoption of New LTIP and Grant of Options
4th Oct 20237:00 amRNSExercise of Share Options & Total Voting Rights
25th Sep 202310:06 amRNSHolding(s) in Company
11th Sep 20237:00 amRNSExercise of Share Options & Total Voting Rights
31st Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
21st Aug 20237:00 amRNSAcquisition
4th Aug 20237:00 amRNSExercise of Share Options & Total Voting Rights
3rd Aug 20231:49 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSChange of Registered Address
14th Jul 20237:00 amRNSExercise of Share Options & Total Voting Rights
27th Jun 20237:00 amRNSExercise of Share Options & Total Voting Rights
13th Jun 20237:00 amRNSPayment of Earnout and Allotment of Shares
12th Jun 20234:44 pmRNSHolding(s) in Company
8th Jun 20237:00 amRNSHalf Year results
18th May 20237:00 amRNSHalf Year 2023 Trading Update
23rd Mar 20232:33 pmRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Trading Update
3rd Mar 20237:00 amRNSPosting of Annual Report and Notice of AGM
15th Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
9th Feb 202311:03 amRNSHolding(s) in Company
3rd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSFinal Results
11th Jan 20237:00 amRNSNotice of Final Results
15th Dec 20227:00 amRNSPayment of Earnout and Allotment of Shares
8th Dec 20221:17 pmRNSHolding(s) in Company
16th Nov 20227:00 amRNSTrading Statement
14th Nov 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.